NEW YORK (GenomeWeb News) – MDxHealth today reported that revenues in its third quarter climbed 62 percent year over year.

It said that total revenues for the three months ended Sept. 30 reached €1.5 million ($1.4 million), up from €925,000 a year ago. During the recently completed quarter MDxHealth tested more than 23,000 prostate biopsies from more than 2,100 patients, its CEO Jan Groen said, adding that the company made "strong progress toward equitable Medicare reimbursement."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.